Population-Based Registry Data over 15 Years Suggests Comparable Overall Survival for CLL Patients Treated with Chemoimmunotherapy and Targeted Therapies As First-Line Treatments

Abraham Varghese.

66th ASH Annual Meeting.

P77 Can some blood cancer patients be considered cured? Findings from the haematological malignancy research network (HMRN)

L. Wright,  S. Crouch,  E. Roman,  A. Smith.

J Epidemiol Community Health

OP40 Patient experiences of living with chronic haematological malignancies and their preferences for psychosocial support: findings from a qualitative study

Rebecca Sheridan,  Dorothy McCaughan,  Ann Hewison,  Eve Roman,  Alexandra Smith,  Russell Patmore,  Debra Howell.

Society for Social Medicine and Population Health Annual Meeting, 2023.

Are patients with acute myeloid leukaemia (AML) or myelodysplastic syndromes (MDS) more likely than the general population to have a preceding cancer? An analysis from the UK’s population-based Haematological Malignancy Research Network (HMRN)

Maxine Lamb,  Eve Roman,  Eleanor Kane,  Alex Smith.

J Epidemiol Community Health

P88 A qualitative interview study in adults with chronic myeloid leukaemia: disease management from patient and practitioner perspectives

Ann Hewison,  Eve Roman,  Alexandra Smith,  Dorothy McCaughan,  Rebecca Sheridan,  Russell Patmore,  Karl Atkin,  Debra Howell.

Society for Social Medicine and Population Health Annual Meeting, 2023.

A UK population-based study of non-Hodgkin lymphoma in teenagers and young adults (TYA) - incidence, treatment and outcomes

R Carr,  A Davies,  B Uttenthal,  M Lamb,  J Fidalgo,  B Carpenter.

International Conference on Malignant Lymphoma (ICML), 2021.

Molecular subclusters of follicular lymphoma: a report from the UK's Haematological Malignancy Research Network

S. Crouch,  D. Painter,  S. Barrans,  E. Roman,  P. Beer,  S. Lacy,  S. Cooke,  N. Webster,  P. Glover,  S. van Hoppe,  P. J. Campbell,  D. J. Hodson,  R. Patmore,  C. Burton,  A. G. Smith,  R. Tooze.

International Conference on Malignant Lymphoma (ICML), 2021.

P-010: An economic model to establish the costs associated with routes of presentation for patients with Myeloma in the UK

Alex Porteous,  Scott Gibson,  Lucy Eddowes,  Mark Drayson,  Guy Pratt,  Hannah Parkin,  Suzanne Renwick,  Ira Laketic-Ljubojevic,  Debra Howell,  Alexandra Smith,  Simon Stern.

18th International Myeloma Workshop, 2021.

Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance

Pietro R Di Ciaccio,  Mark N. Polizzotto,  Kate Cwynarski,  Cathy Burton,  Awachana Jiamsakul,  Mark Bower,  John Kuruvilla,  Silvia Montoto,  Pam McKay,  Wendy Osborne,  Sam Milliken,  Kim Linton,  Kate Manos,  Shireen Kassam,  Nicole Wong Doo,  Anne-Marie Watson,  Pasquale L Fedele,  Costas K. Yannakou,  Stewart Hunt,  Hanna Renshaw,  Nisha Thakrar,  Alexandra Smith,  Daniel Painter,  Alice Maxwell,  Qin Liu,  Rageshri Dhairyawan,  Graeme Ferguson,  Keir Pickard,  Nada Hamad.

American Society of Hematology Annual Meeting and Exposition, 2020.

Thu0604 Undiagnosed Rheumatic Disease in Newly Presenting Mgus Patient

Q. Zhou,  K. Wang,  L. Rahman,  A. Watad,  S. Savic,  E. Roman,  D. Mcgonagle.

Annals of the Rheumatic Diseases

An international multicentre study of consecutively diagnosed patients with ALCL: outcomes following first-line therapy in routine clinical practice

Nicolas Martinez-Calle,  Amy A. Kirkwood,  Maxine Lamb,  Alexandra G Smith,  Kate Manos,  Caroline Shrubsole,  Nicola Gray,  Sapna Ladani,  Katharine Lewis,  Mark Bishton,  Matthew Ahearne,  Eliza Hawkes,  Wendy Osborne,  G Colins,  Catherine Burton,  Christopher P Fox.

60th Annual Scientific Meeting of the British Society for Haematology, 2020.

TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes

Elsa Bernard,  Yasuhito Nannya,  Tetsuichi Yoshizato,  Robert Hasserjian,  Ryunosuke Saiki,  Sean Devlin,  Heinz Tuechler,  Araxe Sarian,  Luca Malcovati,  Francesc Sole,  Detlef Haase,  Maria Creignou,  Max Levine,  Ulrich Germing,  Catherine Cargo,  Yanming Zhang,  Juan Medina,  Juan Arango Ossa,  Julie Schanz,  Arjan van de Loosdrecht,  Martin Jädersten,  John Bennett,  Magnus Tobiasson,  Olivier Kosmider,  Matilde Follo,  Felicitas Thol,  Ronald Pinheiro,  Valeria Santini,  Ioannis Kotsianidis,  Jacqueline Boultwood,  Fabio Santos,  Senji Kasahara,  Takayuki Ishikawa,  Hisashi Tsurumi,  Akifumi Takaori-Kondo,  Toru Kiguchi,  Chantana Polprasert,  Virginia Klimek,  Michael Savona,  Monika Belickova,  Christina Ganster,  Lionel Ades,  Matteo Porta,  Alexandra Smith,  Yesenia Werner,  Minal Patel,  Agnes Viale,  Katelynd Vanness,  Donna Neuberg,  Kristen Stevenson,  Kamal Menghrajani,  Kelly Bolton,  Pierre Fenaux,  Andrea Pellagatti,  Uwe Platzbecker,  Michael Heuser,  Peter Valent,  Shigeru Chiba,  Yasushi Miyazaki,  Carlo Finelli,  Marina Voso,  Lee-Yung Shih,  Michaela Fontenay,  Joop Jansen,  José Cervera,  Yoshiko Atsuta,  Norbert Gattermann,  Benjamin Ebert,  Rafael Bejar,  Peter Greenberg,  Mario Cazzola,  Eva Hellstrom Lindberg,  Seishi Ogawa,  Elli Papaemmanuil.

American Society of Hematology Annual Meeting and Exposition, 2019.

An International Multicentre Study of Consecutively Diagnosed Patients with ALCL: Outcomes Following First-Line Therapy in Routine Clinical Practice

Nicolas Martinez-Calle,  Amy Kirkwood,  Maxine Lamb,  Alexandra Smith,  Kate Manos,  Caroline Shrubsole,  Nicola Gray,  Sapna Ladani,  Katharine Lewis,  Mark Bishton,  Matthew Ahearne,  Eliza Hawkes,  Wendy Osborne,  Graham Collins,  Cathy Burton,  Christopher Fox.

American Society of Hematology Annual Meeting and Exposition, 2019.

Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel

Findlay Bewicke-Copley,  Koorosh Korfi,  Shamzah Araf,  Emil Arjun Kumar,  Thomas Cummin,  Margaret Ashton-Key,  Sharon Barrans,  Suzan Van Hoppe,  Cathy Burton,  Mohamed Elshiekh,  Simon Rule,  Nicola Crosbie,  Andrew Clear,  Maria Calaminici,  David Scott,  Lisa Rimsza,  Menon Geetha,  Chulin Sha,  Michael Bentley,  Ai Nagano,  Andrew Davies,  Daniel Painter,  Alexandra Smith,  John Gribben,  Kikkeri Naresh,  David Westhead,  Jessica Okosun,  Peter Johnson,  Jun Wang,  Jude Fitzgibbon.

American Society of Hematology Annual Meeting and Exposition, 2019.

Targeted Sequencing Predicts the Development of Myeloid Malignancies and Clinical Outcome in Patients with Unexplained Cytopenia

Catherine Cargo,  Kelly Bolton,  Tumas Beinortas,  Paul Glover,  Michael Short,  Alexandra Smith,  Jan Taylor,  Paul Evans,  Elli Papaemmanuil,  Simon Crouch.

American Society of Hematology Annual Meeting and Exposition, 2019.

Hospital activity before and after diagnosis of monoclonal gammopathy of undetermined significance (MGUS)

Maxine Lamb,  Eleanor Kane,  Alexandra Smith,  Eve Roman.

Cancer Conference of the National Cancer Research Institute, 2019.

36 Preferred and actual place of death in patients with haematological malignancies

Rebecca Sheridan,  Eve Roman,  Alexandra Smith,  Russell Patmore,  Martin Howard,  Debra Howell.

The Annual Marie Curie Palliative Care Research Conference, jointly with the Palliative Care Section of the Royal Society of Medicine 2019.

Population-Based Outcomes in Large B-Cell Lymphoma by Who Subtype: Findings from the Uk's Haematological Malignancy Research Network

R. Patmore,  A. Smith,  S. Barrans,  D. Painter,  D. Howell,  C. Burton,  E. Roman.

International Conference on Malignant Lymphoma (ICML), 2019.

Defining Burkitt-Like Lymphoma with 11q Aberration in a Specialised Uk Haematopathology Diagnostic Service

S. Barrans,  D. Painter,  S. van Hoppe,  A. Smith,  C. Sha,  F. Cucco,  M. Du,  D. Westhead,  A. Davies,  P. Johnson,  E. Roman,  C. Burton.

International Conference on Malignant Lymphoma (ICML), 2019.

Does Life-Expectancy in Patients with Diffuse Large B-Cell Lymphoma Return to Normal? Findings from a UK-Based Population-Based Study

Russell Patmore,  Alexandra Smith,  Han-I. Wang,  Maxine Lamb,  Debra Howell,  Cathy Burton,  Eve Roman.

American Society of Hematology Annual Meeting and Exposition, 2018.

Prognostic Significance of MYC Single, Double, Triple Hit and MYC-Translocation Partner Status in Diffuse Large B-Cell Lymphoma - a Study By the Lunenburg Lymphoma Biomarker Consortium (LLBC)

Andreas Rosenwald,  Laurie H. Sehn,  Delphine Maucort-Boulch.

American Society of Hematology Annual Meeting and Exposition, 2018.

Emergency presentation and survival from Hodgkin lymphoma

Maxine Lamb,  Alexandra Smith,  Eve Roman,  Debra Howell,  Timothy Bagguley,  Russell Patmore,  Cathy Burton.

Public Health England Cancer Services, Data and Outcomes Conference, 2018.

Using multi-state modelling to facilitate informed personalised treatment planning in Follicular Lymphoma

Stuart Edward Lacy,  Han I. Wang,  Alexandra Gwen Smith,  Eve Roman,  Simon Crouch.

7th Survival Analysis for Junior Researchers Conference, 2018.

Longitudinal Analyses of the Genomic, Transcriptomic, and T Cell Repertoire in Diffuse Large B Cell Lymphoma Demonstrates Changes in Signaling and Immune Recognition at Relapse

Shamzah Araf,  Koorosh Korfi,  Ai Nagano,  Thomas E. C. Cummin,  Michael Bentley,  Aaron R. Thorner,  Margaret Ashton-Key,  Maria Calaminici,  Andrew James Clear,  Andrew Davies,  Sharon Barrans,  Suzan Van Hoppe,  Cathy Burton,  Simon Rule,  Nicola Crosbie,  Daniel Painter,  Alexandra Smith,  David M. Weinstock,  David R. Westhead,  Jessica Okosun,  John G. Gribben,  Peter Johnson,  Jude Fitzgibbon.

American Society of Hematology Annual Meeting and Exposition, 2017.

UK Utility Elicitation in Patients with Follicular Lymphoma

H. Wang,  A. Smith,  G. Yu,  E. Aas,  T. Bagguley,  D. Howell,  E. Roman,  C. Burton,  R. Patmore.

The Professional Society for Health Economics and Outcomes Research (ISPOR), 2017.

An Economic Evaluation Model for Follicular Lymphoma (FL): Predicting Treatment Cost, Life Expectancy and Quality-Adjusted Life Year of Different Scenarios Using UK Population Based Observational Data

H. Wang,  E. Aas,  A. Smith,  E. Roman,  S. Crouch,  C. Burton,  R. Patmore.

The Professional Society for Health Economics and Outcomes Research (ISPOR), 2017.

Gene Expression Profiling and Mutation Analysis Can Aid Treatment Decision Making in Aggressive B Cell Lymphoma Patients

C.h. Burton,  S. Barrans,  S. Van Hoppe,  C. Sha,  J. Taylor,  P. Evans,  D. Painter,  A. Smith,  S. Crouch,  J.r. Goodlad,  E. Roman,  D. Westhead,  A. Davies,  P.w. Johnson.

International Conference on Malignant Lymphoma (ICML), 2017.

Molecular analysis of primary cutaneous diffuse large B-cell lymphoma, leg type

J.r. Goodlad,  S. van Hoppe,  S. Ahmed,  S.l. Barrans,  D. Painter,  M. Care,  J. Taylor,  P. Evans,  M. Bentley,  R.m. Tooze,  A. Smith,  S. Crouch,  E. Roman,  D.r. Westhead,  C. Burton.

International Conference on Malignant Lymphoma (ICML), 2017.

Validation of Plasma Cell Immunophenotype As a Biomarker to Identify High-Risk Smoldering Myeloma

Andy C. Rawstron,  Alex Smith,  Ruth Mary de Tute,  Dan Painter,  Eve Roman,  Roger G. Owen.

American Society of Hematology Annual Meeting and Exposition, 2016.

Mantle Cell Lymphoma Management and Outcome in the U.K's Population-Based Haematological Malignancy Research Network

Russell Patmore,  Alexandra Smith,  Simon Appleton,  Debra Howell,  Roderick J. Johnson,  Cathy H. Burton,  Eve Roman.

American Society of Hematology Annual Meeting and Exposition, 2016.

Similarity Search Methods As an Alternative to Sub-Type Characterisation in Aggressive Lymphomas

Chulin Sha,  Sharon Barrans,  Andrew Jack,  Cathy H. Burton,  Alexandra Smith,  Eve Roman,  Dan Painter,  Simon Crouch,  Reuben M. Tooze,  Matthew Care,  David R. Westhead.

American Society of Hematology Annual Meeting and Exposition, 2016.

Novel Targeted Therapies and Their Impact on Survival from Multiple Myeloma (MM) and Chronic Lymphocytic Leukaemia (CLL) in the Real World

Alexandra G. Smith,  Timothy Bagguley,  Eve Roman,  Andy C. Rawstron,  James R. Bailey,  Debra Howell,  John Ashcroft,  Burton Cathy,  Gordon Cook,  Russell Patmore.

American Society of Hematology Annual Meeting and Exposition, 2016.

Why Do So Many Patients With Haematological Malignancy Die in Hospital and How Do Family Physicians Perceive Their Role in Their Care?

D. M. McCaughan,  E Roman, E,  A. G. Smith,  D. A. Howell.

National American Primary Care Research Group Annual Meeting, 2016.

Emergency presentation in aggressive lymphoma and impact on survival: a report from the Haematological Malignancy Research Network

EV Kane,  AG Smith,  D Howell,  S Crouch,  E Roman.

Society for Social Medicine Annual Scientific Meeting, 2016.

Key beliefs about reasons for hospital deaths in patients with blood cancers: Qualitative findings from a UK study

D. M. McCaughan,  D. A. Howell.

Society for Social Medicine Annual Scientific Meeting, 2016.

Why do patients with haematological malignancies die in hospital? Qualitative findings from a UK study

Dorothy McCaughan,  Eve Roman,  Alex Smith,  Debra Howell.

Association for Palliative Medicine, 2016.

Factors associated with hospital death in patients with haematological malignancies: findings from a UK population-based study

Andrew Turner,  Eve Roman,  Alex Smith,  Debra Howell.

Association for Palliative Medicine, 2016.

Preferred and actual place of death in patients with blood cancers: Findings from a UK population-based study

D. A. Howell,  A. K. Turner,  A. G. Smith,  E. Roman.

Society for Social Medicine Annual Scientific Meeting, 2016.

Routes to diagnosis of myeloma: findings from a UK population-based study

D. A. Howell,  S. Appleton,  A. G. Smith,  E. Roman.

Society for Social Medicine Annual Scientific Meeting, 2016.

The Leeds Haematological Malignancy Diagnostic Service Outreach postal monitoring service for patients with indolent B-lymphoproliferative and plasma cell disorders: 10-year evaluation of laboratory parameters and symptom self-assessment for early identification of disease progression

N Appleby,  D Painter,  A Smith,  V Martin,  H Greenwood,  C Mountain,  R Jones,  R Owen,  A Rawstrom.

XXXVI World Congress of the International Society of Hematology, 2016.

Poor Outcomes in HIV Negative and HIV Positive Patients with Plasmablastic Lymphoma (PBL) in a Population Based Patient Study

N Appleby,  R Cullen,  D. Painter,  A. Smith,  E. Roman,  S. Barrans,  S. O'Connor,  C. Burton,  A. Jack,  R. Owen,  R. Tooze.

American Society of Hematology Annual Meeting and Exposition, 2015.

Predicting Time to Treatment in Follicular Lymphoma Using Population-Based Data

R.D. Patmore,  A. Smith,  C. Burton,  E. Roman,  S. Crouch.

American Society of Hematology Annual Meeting and Exposition, 2015.

Acute Myeloid Leukaemia Treatment in Adults in Norway Five Year Survival and Costs

Alette Glasø Skifjeld,  Beate Bjørnstad,  Yngvar Fløisand,  Eline Aas.

American Society of Hematology Annual Meeting and Exposition, 2015.

Comparison Of Different Costing Methods

H. Wang,  E. Aas,  E. Roman,  A. Smith.

The Professional Society for Health Economics and Outcomes Research (ISPOR), 2015.

Method Comparison Of Censoring Cost Analyses

H. Wang,  E. Aas,  E. Roman,  A. Smith.

The Professional Society for Health Economics and Outcomes Research (ISPOR), 2015.

Mantle cell lymphoma management and outcome in the UK's population - based haematological malignancy research network

R Patmore,  A. G. Smith,  J Appleton,  D. A. Howell,  R. Johnson,  C. Burton,  E Roman.

International Conference on Malignant Lymphoma (ICML), 2015.

Chronic lymphocytic leukaemia treatment and outcome in the UK's population- based haematological malignancy research network

R Patmore,  A. G. Smith,  T. Bagguley,  D. A. Howell,  J.R. Bailey,  C. Burton,  E Roman.

International Conference on Malignant Lymphoma (ICML), 2015.

Impact of patient's age on treatment and outcome in diffuse large B-cell lymphoma (DLBCL): an analysis from the UK's population-based Haematological Malignancy Research Network (National Cancer Intelligence Network Cancer Outcomes Conference, June 2015)

Alexandra Smith,  Eve Roman,  Debra Howell,  Russell Patmore.

National Cancer Intelligence Network Cancer Outcomes Conference, 2015.

Recommendations for monitoring of newly diagnosed patients with CLL and MBL: 10-year experience from the UK Haematological Malignancy Research Network (HMRN)

A Rawstron,  A Smith,  RM de Tute,  C Burton,  E Roman,  P Hillmen.

XVI International Workshop on Chronic Lymphocytic Leukemia, 2015.

Detection of BCL2 Gene Rearrangements in the Reed-Sternberg Cells of Composite Lymphomas or Newly Diagnosed Hodgkin Lymphoma in Patients with a Previous Diagnosis of Follicular Lymphoma (American Society of Hematology, San Francisco, December 2014)

Sheila J. M. O'Connor,  Kathryn Turner,  Catherine H. Burton,  Andrew Jack.

American Society of Hematology Annual Meeting and Exposition, 2014.

Early Diagnosis of Myelodysplastic Syndromes Can be Improved By Deep Sequencing and Array Based Cytogenetics (American Society of Hemtaology, San Francisco, December 2014)

Catherine Cargo,  Nicola Rowbotham,  Paul Evans,  Sharon Barrans,  Simon Crouch,  Andrew Jack.

American Society of Hematology Annual Meeting and Exposition, 2014.

Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort: A Patient Level Simulation Model

H. I. Wang,  A. Smith,  E. Roman,  S. Crouch,  A. Jack,  R. Patmore.

The Professional Society for Health Economics and Outcomes Research (ISPOR), 2014.

Palliative Care in Haematological Malignancy

D.A. Howell.

4th Congress on Palliative Care, 2014.

Patient and Public Involvement in the Haematological Malignancy Research Network

J Blase,  D. A. Howell,  A. G. Smith,  E. Roman.

University of York PPI Conference, 2014.

Bone Marrow Staging For Lymphoma: A Re-Evaluation Of Clinical Utility

Andrew Jack,  Daniel Painter,  Alexandra Smith,  Eve Roman,  Ruth M. de Tute,  Russell Patmore.

American Society of Hematology Annual Meeting and Exposition, 2013.

Skeletal-Related Events In Myeloma: A Population-Based Study

John Ashcroft,  Timothy Bagguley,  Alexandra Smith,  Han-I. Wang,  Debra Howell,  Hazem A. Sayala,  Gordon Cook,  Andrew Jack,  Russell Patmore,  Eve Roman.

American Society of Hematology Annual Meeting and Exposition, 2013.

Development Of A Cross Platform, 2-Way Gene Expression Classifier To Distinguish Burkitt Lymphoma From DLBCL, and Assessment Of The Potential Impact Of Its Use In Treatment Decision Making

Sharon Barrans,  Sha Chulin,  Alex Smith,  Simon Crouch,  Lisa Worrillow,  Eve Roman,  David Westhead,  Andrew Jack.

American Society of Hematology Annual Meeting and Exposition, 2013.

The Prognosis Of Transformed Follicular Lymphoma Is Determined By Prior Exposure To Chemotherapy

Andrew Jack,  Alexandra Smith,  Ruth de Tute,  Daniel Painter,  Eve Roman,  Russell Patmore.

American Society of Hematology Annual Meeting and Exposition, 2013.

Social Inequality Is An Important Risk Factor For Death From Chronic Myeloid Leukaemia: Findings From a UK Population-Based Cohort

Alexandra Smith,  Eve Roman,  Daniel Painter,  Debra Howell,  Graeme Smith,  Paul Evans,  Russell Patmore,  Andrew Jack.

American Society of Hematology Annual Meeting and Exposition, 2013.

Differences in Medical Cost and Survival Between Trial and Non-Trial Patients with Acute Myeloid Leukaemia – A UK Population-Based Propensity Analysis

H. I. Wang,  E. Aas,  E. Roman,  D. Howell,  D. Painter,  A. Smith.

The Professional Society for Health Economics and Outcomes Research (ISPOR), 2013.

Variations in time-to-diagnosis and symptoms of leukaemias, lymphomas and myeloma: findings from the Haematological Malignancy Research Network

D. A. Howell,  A.G. Smith,  R. Patmore,  U Macleod,  A. Jack,  E. Roman.

National Awareness and Early Diagnosis Initiative (NAEDI) Research Conference, 2013.

Long-Term Medical Costs and Life Expectancy of Acute Myeloid Leukaemia: A Probabilistic Decision Model

H. I. Wang,  D. Howell,  A. Smith,  E. Roman,  E. Aas.

The Professional Society for Health Economics and Outcomes Research (ISPOR), 2012.

Identifying Phenotypically and Clinically Distinct Entities within the Spectrum of Marginal Zone Lymphoma and Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia (American Society of Hematology, San Diego, December 2011)

Ruth M de Tute,  Eve Roman,  Andrew Jack,  Roger G Owen,  Andy Rawstron.

American Society of Hematology Annual Meeting and Exposition, 2011.

A Unified Prognostic Model for Myelodysplastic Syndrome and Acute Myeloid Leukaemia Based on Flow Cytometric Blast Count (American Society of Hematology, San Diego, December 2011)

Alexandra Smith,  Simon Crouch,  Dan Painter,  Eve Roman,  Matt Cullen,  Fiona Bennett,  Catherine Cargo,  Andrew Jack.

American Society of Hematology Annual Meeting and Exposition, 2011.

Evaluation of the completeness of national haematological malignancy registration: comparison of national data with a specialist population-based register

E Roman,  AG Smith,  SE Oliver,  E Bolton,  JRY Ross,  R Patmore,  A Jack.

RQ-PCR Provides a Superior Alternative to Immunohistochemistry In Defining Prognostic Groups In DLBCL, and Predicts Treatment Failure with CHOP-R (American Society of Hematology, Orlando, December 2010)

Lisa Worrillow,  Sharon Barrans,  Simon Crouch,  Matthew Care,  Alex Smith,  Russell Patmore,  Reuben Tooze,  Eve Roman,  Andrew Jack.

American Society of Hematology Annual Meeting and Exposition, 2010.

Gene Expression Profiling Using the Illumina 'DASL' Platform on RNA Extracted From Formalin Fixed Paraffin Embedded (FFPE) Tissue Identifies Distinct Prognostic Groups In CHOP-R Treated DLBCL (American Society of Hematology, Orlando, December 2010)

Sharon Barrans,  Lisa Worrillow,  Matthew Care,  Simon Crouch,  Alex Smith,  Russell Patmore,  Andrew Davies,  Reuben Tooze,  Eve Roman,  Andrew Jack.

End of Life in Haematological Malignancy

D. A. Howell,  A. G. Smith,  E. Roman.

YCN Sub Regional Palliative and End of Life Care Educational Event, 2010.

End of life and haematological malignancy: Destined to die in hospital?

D. A. Howell,  E. Roman,  H. Cox,  A. G. Smith,  R. Patmore,  A. Garry,  M. R. Howard.

50th Annual Scientific Meeting of the British Society for Haematology, 2010.

Teaching practical laboratory skills in the 21st century

S.J.M. O'Connor,  C. Burton,  J Blase,  W Curson,  J. Doughty,  T. Lightfoot,  A.S. Jack.

49th Annual Scientific Meeting of the British Society for Haematology, 2009.

Haematopathology Diagnostic Skills Acquired in a Virtual Laboratory: Practical Teaching in the 21st Century

S.J.M. O'Connor,  C. Burton,  J Blase,  W Curson,  J. Doughty,  T. Lightfoot,  A. Jack.

14th Congress of the European Hematology Association, 2009.

Rearrangements of MALT1, IgH, FOXP1, BCL3 and PAX5 Are Rare Events in Extranodal Marginal Zone Lymphoma in the UK. (American Society of Hematology, December 2006)

Sharon L. Barrans,  Kathryn Turner,  Sheila J.M. O'Connor,  Andrew S. Jack,  Roger G. Owen.

American Society of Hematology Annual Meeting and Exposition, 2006.

A Highly Effective Model of Risk Assessment in Diffuse Large B Cell Lymphoma (DLBCL) Using Classification and Regression Tree (CART) Analysis. (American Society of Hematology, December 2006)

Sharon L. Barrans,  Alex Smith,  Sheila J.M. O'Connor,  Kathryn Turner,  Russell Patmore,  Roger G. Owen,  Eve Roman,  Andrew Jack.

American Society of Hematology Annual Meeting and Exposition, 2005.